Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis. 

Biotechnology

Attralus Therapeutics

Attralus Therapeutics' headquarters in South San Francisco, CA, United States

Mark Timney

Spencer Guthrie

Jonathan Wall

Glen Firestone

Gregory Bell

James Testa

Rahul Kakkar

Jeff Kelly

Mathew Maurer

Jake Bauer

Alexander Denner

Corey Goodman

Morie Gertz

Jaume Pons

Nancy Miller-Rich

Richard Gaster

The Regulatory and Scientific Development team at Attralus Therapeutics is responsible for guiding the regulatory strategy and scientific rigor behind the development of transformative therapies for systemic amyloidosis. This team collaborates closely across disciplines to ensure compliance with regulatory standards, facilitates product development from laboratory to clinic, and engages with health authorities to advance therapeutic candidates effectively through the pipeline. Their expertise encompasses regulatory affairs, quality assurance, CMC (chemistry, manufacturing, and controls), toxicology, and analytical development, ensuring that Attralus's innovations meet the highest safety and efficacy standards.

Regulatory and Scientific Development

The Clinical Operations and Development team at Attralus Therapeutics is responsible for overseeing the design, planning, and execution of clinical trials aimed at evaluating potential treatments for systemic amyloidosis. This team ensures compliance with regulatory standards, manages project timelines, and coordinates cross-functional efforts to facilitate data collection and analysis, ultimately driving the progression of innovative therapies from the lab to patients.

Clinical Operations and Development

The Leadership Team at Attralus Therapeutics is responsible for steering the company's strategic vision and operational execution, ensuring the development of innovative therapies for systemic amyloidosis. Comprising experts in business, medicine, finance, and scientific research, the team collaborates to drive clinical development, secure funding, and navigate regulatory landscapes, all while fostering a culture of innovation and patient-centered care. Their collective expertise guides Attralus in its mission to improve patient outcomes and achieve sustainable growth.

Leadership Team

Attralus Therapeutics

Org chart

Board & advisors

Teams

Regulatory and Scientific Development

Clinical Operations and Development

Leadership Team

Offices

Attralus Therapeutics

Org chart

Board & advisors

Teams

Regulatory and Scientific Development

Clinical Operations and Development

Leadership Team

Offices

Related companies